Incannex Healthcare Inc.

NasdaqGM:IXHL Stock Report

Market Cap: US$32.3m

Incannex Healthcare Balance Sheet Health

Financial Health criteria checks 6/6

Incannex Healthcare has a total shareholder equity of $6.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $16.0M and $9.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$3.63m
EquityUS$6.60m
Total liabilitiesUS$9.45m
Total assetsUS$16.05m

Recent financial health updates

Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth?

Feb 05
Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth?

Recent updates

Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem

Feb 21
Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem

Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth?

Feb 05
Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth?

Incannex rises 9% after Australia approval to begin phase 1 trial of anti-inflammatory drug

Jul 21

Financial Position Analysis

Short Term Liabilities: IXHL's short term assets ($15.2M) exceed its short term liabilities ($9.2M).

Long Term Liabilities: IXHL's short term assets ($15.2M) exceed its long term liabilities ($221.0K).


Debt to Equity History and Analysis

Debt Level: IXHL is debt free.

Reducing Debt: IXHL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IXHL has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: IXHL is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:48
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Incannex Healthcare Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arron AatkarEdison Investment Research
David Joseph StormsStonegate Capital Partners, Inc.